ADIL
No price yet
Announcements
Nothing here yet
Daily updates
FDA designations
Nothing here yet
News
- Adial Pharmaceuticals submitted an application to the FDA Commissioner's National Priority Voucher pilot program for AD04 clinical developmentApr 27, 2026
- Adial praised a congressional directive advancing alternative clinical trial endpoints for substance use disorders, strengthening the regulatory pathway for AD04Feb 5, 2026
- Adial Pharmaceuticals encouraged by U.S. Senate support for expanded clinical trial endpoints beyond abstinence in alcohol and substance use disorder treatmentsAug 20, 2025
- Adial Pharmaceuticals moves forward toward Phase 3 development for AD04Jun 11, 2025
- Adial Pharmaceuticals granted an End of Phase 2 meeting by the U.S. Food and Drug Administration.May 8, 2025